查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433548

STD诊断市场规模、份额、趋势分析报告：按产品、按应用、按技术、按测试地点、按地区、细分市场预测，2024-2030年

STD Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology, By Location Of Testing, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 156 Pages | 商品交期: 2-10个工作天内

价格

性病诊断市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2024年至2030年全球性病诊断市场规模将以7.18%的复合年增长率成长，2030年将达到163.6亿美元。

性行为感染（STD）疾病负担的增加以及政府和非营利组织为提高意识并鼓励青少年定期筛检所做的努力是促进市场成长的关键因素。根据世界卫生组织资料，全球每年约有3.74亿人新感染梅毒、淋病、披衣菌、披衣菌感染等疾病。

下一代HIV检测套组和多重PCR产品等先进产品的开发和商业化使医生能够及时诊断和区分各种性传播感染并提供适当的治疗。韩国诊断公司 Seegene, Inc. 提供广泛的 Allplex、Anyplex 和 Seeplex 产品组合，可检测各种病原体。例如，Allplex STI/BV Panel Assay 可以在一次测试中区分出 28 种病原体。 2022年4月，Seegene, Inc.宣布开发Allplex HPV HR检测。

Allplex HPV HR 检测是世界上第一个商业化的「3 Ct」PCR 检测。 Seegene 专注于将此技术应用于整个产品链，包括 STI、尿道感染(UTI) 和呼吸道病毒 (RV) 检测。这项策略性技术进步预计将为该公司扩大在性行为感染传染病（STD）诊断行业的份额提供额外的优势。

HIV 国家战略计画是 2030 年消除美国人类免疫力缺乏病毒流行的蓝图。该爱滋病毒计画的实施期限为2021年至2025年，是该国第三个国家爱滋病毒五年计划，其十年目标是到2030年将新发人类免疫力缺乏病毒感染率减少一半90%。此外，国家病毒性肝炎策略计画重点关注性传播B型肝炎和C型肝炎。 2021 年 1 月，美国卫生与公众服务部 (HHS) 发布了一项国家战略，以应对病毒性肝炎对美国造成的重大且可预防的公共卫生威胁。政府的有益行动正在为性病诊断产业的扩张创造有利的氛围。

两家公司正在做出策略性努力，支持新产品的开发和监管核准，并加强产品系列。例如，2020 年 8 月，DiaSorin, Inc. 获得美国FDA 的 510(k)核准，推出 LIAISON XL MUREX 抗 HBe。这用于诊断 HBV 感染。此免疫测量产品的工作原理是化学冷光。

性病诊断市场报告亮点

  • 2023年，消耗品领域占据最大的市场占有率，并且由于高检测率和多种STD诊断检测的商业化，预计在预测期内将保持其地位。
  • 从技术角度来看，由于高通量 PCR 技术的使用增加以及针对 HIV 检测的 NAAT 检测的推荐，预计分子诊断领域在预测期内将以最快的复合年增长率增长。同时检测多种病原体的多重 PCR 检测的发展也有望促进 STD 诊断产业的成长。
  • 从应用来看，HIV 检测领域预计将在 2023 年主导性病诊断产业。这是由于爱滋病毒高盛行率、分子检测产品核可增加以及政府的有利措施等因素所造成的。
  • 由于开发中国家性病检测率上升、可支配收入增加以及性病患病率较高，亚太国家预计将在预测期内经历最快的成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 STD 诊断市场变数、趋势和范围

  • 绘製普及和成长前景图
  • 从使用者观点分析
  • 监管和报销框架
  • 市场驱动因素分析
    • 全球性行为感染负担增加
    • 性病诊断技术进步
    • 政府鼓励早期诊断和治疗的倡议
  • 市场限制因素分析
    • 性行为感染疫苗接种范围
  • COVID-19 影响分析
  • SWOT 分析，按因素（政治/法律、经济、技术）
  • 产业分析-波特五力分析

第 4 章 STD 诊断市场：細項分析（按产品），2018-2030 年

  • 性病诊断市场：产品波动分析
  • 设备和服务
  • 消耗品
  • 软体

第五章 STD 诊断市场：按应用細項分析，2018-2030 年

  • 性病诊断市场：应用变化分析
  • CT/NG测试
  • 梅毒测试
  • 单纯疱疹病毒检测
  • HPV检测
  • 爱滋病毒检测
  • 解脲支原体和霉浆菌检测
  • 滴虫测试
  • VZV测试
  • 戈诺罗耐热测试
  • 其他考试

第六章 STD 诊断市场：依技术細項分析，2018-2030 年

  • 性病诊断市场：技术变迁分析
  • 分子诊断
  • 免疫检测
  • 其他的

第 7 章 STD 诊断市场：細項分析（按测试地点），2018-2030 年

  • 性病诊断市场：检测地点的变化分析
  • 临床检查
  • 就地检验

第 8 章 STD 诊断市场：細項分析，按地区，2018-2030 年

  • 性病诊断市场：按地区分類的展望
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第九章性病诊断市场：竞争分析

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 供应商形势
  • 2022年主要企业市场占有率分析
  • 上市公司
  • 私人公司
  • 公司简介
    • BD
    • F. HOFFMANN-LA ROCHE LTD.
    • HOLOGIC INC. (GEN PROBE)
    • ABBOTT
    • CEPHEID (DANAHER)
    • QIAGEN
    • ORASURE TECHNOLOGIES, INC
    • BIO-RAD LABORATORIES, INC.
    • THERMO FISHER SCIENTIFIC, INC.
    • SEEGENE INC.
    • DIASORIN SPA

第10章结论

Product Code: 978-1-68038-686-8

STD Diagnostics Market Growth & Trends:

The global STD diagnostics market size is expected to reach USD 16.36 billion by 2030, expanding at a CAGR of 7.18% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing disease burden of Sexually Transmitted Disease (STD) and efforts by government & non-profit organizations to increase awareness and encourage regular screenings among the younger population are the key factors augmenting the market growth. According to WHO data, around 374 million new cases of syphilis, gonorrhea, chlamydia, and trichomoniasis are recorded every year globally.

Development and commercialization of advanced products, such as next-generation HIV testing kits and multiplex PCR products, enable physicians to timely diagnose & distinguish a range of STIs and provide appropriate treatment. Seegene, Inc., a South Korea-based diagnostic company, provides a wide portfolio of Allplex, Anyplex, and Seeplex products that detect various causative agents. For instance, Allplex STI/BV Panel Assay can distinguish 28 causative agents in a single test. In April 2022, Seegene, Inc. announced the development of Allplex HPV HR Detection.

Allplex HPV HR Detection is the world's first commercialized '3 Ct' PCR assay. Seegene is focusing to apply this technology to its entire product chain, including STI, Urinary Tract Infection (UTI), and Respiratory Virus (RV) assays. This strategic technological advancement is expected to provide an additional advantage to the company that can help increase its share in the Sexually Transmitted Disease (STD) diagnostics industry.

The HIV National Strategic Plan is a roadmap for eliminating the human immunodeficiency virus pandemic in the U.S. by 2030. The HIV Plan, which will run from 2021 to 2025, is the country's third five-year national HIV plan in a row, with a 10-year goal of halving new human immunodeficiency virus infections by 90% by 2030. Furthermore, the Viral Hepatitis National Strategic Plan focuses on hepatitis B and C, which are sexually transmitted. In January 2021, the US Department of Health and Human Services (HHS) released a nationwide strategy to address the preventable, substantial public health threats posed by viral hepatitis in the United States. The government's beneficial actions create a favorable atmosphere for the expansion of the STD diagnostics industry.

Companies are engaging in strategic initiatives that aid in the development of new products, and regulatory approvals as well as enhance their STD diagnostics product portfolio. For instance, in August 2020, DiaSorin, Inc. received 510 (k) approval from U.S. FDA for introducing LIAISON XL MUREX anti-HBe. It is used for the diagnosis of HBV infection. This immunoassay product works on the principle of chemiluminescence.

STD Diagnostics Market Report Highlights:

  • In 2023, the consumables segment accounted for the largest market share and is anticipated to maintain its position over the forecast period owing to high testing rates for the diagnosis of STDs and the commercialization of several assays
  • Based on technology, the molecular diagnostics segment is estimated to grow at the fastest CAGR during the forecast period owing to the increasing use of high-throughput PCR technology and the recommendation of NAAT tests for HIV testing. The development of multiplex PCR tests for the simultaneous detection of multiple pathogens is also expected to contribute to the STD diagnostics industry's growth
  • Based on application, the HIV testing segment is expected to dominate the STD diagnostics industry in 2023, due to factors such as the high incidence rate of the disease, increasing product approvals for molecular tests, and favorable government initiatives
  • Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increase in testing rates for STDS, a rise in disposable income, and high disease prevalence of STD in developing countries

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Product And Application Snapshot
  • 2.3 Technology And Location Of Testing Snapshot
  • 2.4 Competitive Snapshot

Chapter 3 STD Diagnostics Market Variables, Trends, And Scope

  • 3.1 Penetration And Growth Prospect Mapping
  • 3.2 User Perspective Analysis
  • 3.3 Regulatory And Reimbursement Framework
  • 3.4 Market Driver Analysis
    • 3.4.1 Growing Global Disease Burden Of STDs
    • 3.4.2 Technological Advancements In STD Diagnostics
    • 3.4.3 Government Initiatives Encouraging Early Diagnosis And Treatment
  • 3.5 Market Restraint Analysis
    • 3.5.1 Vaccination Coverage For STDs
  • 3.6 Covid-19 Impact Analysis
  • 3.7 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.8 Industry Analysis - Porter's

Chapter 4 STD Diagnostics Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 4.1 STD Diagnostics Market: Product Movement Analysis
  • 4.2 Instruments And Services
    • 4.2.1 Instruments And Services Market, 2018 - 2030 (USD Million)
  • 4.3 Consumables
    • 4.3.1 Consumables Market, 2018 - 2030 (USD Million)
  • 4.4 Software
    • 4.4.1 Software Market, 2018 - 2030 (USD Million)

Chapter 5 STD Diagnostics Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 5.1 STD Diagnostics Market: Application Movement Analysis
  • 5.2 Ct/Ng Testing
    • 5.2.1 Ct/Ng Testing Market, 2018 - 2030 (USD Million)
  • 5.3 Syphilis Testing
    • 5.3.1 Syphilis Testing Market, 2018 - 2030 (USD Million)
    • 5.3.2 Syphilis Pcr Testing Market, 2018 - 2030 (USD Million)
    • 5.3.3 Syphilis Non-Pcr Testing Market, 2018 - 2030 (USD Million)
  • 5.4 Hsv Testing
    • 5.4.1 Hsv Testing Market, 2018 - 2030 (USD Million)
    • 5.4.2 Herpes Simplex Virus Pcr Testing Market, 2018 - 2030 (USD Million)
    • 5.4.3 Herpes Simplex Virus Non-Pcr Testing Market, 2018 - 2030 (USD Million)
  • 5.5 Hpv Testing
    • 5.5.1 Hpv Testing Market, 2018 - 2030 (USD Million)
  • 5.6 Hiv Testing
    • 5.6.1 Human Immunodeficiency Virus Testing Market, 2018 - 2030 (USD Million)
  • 5.7 Ureaplasma & Mycoplasma Testing
    • 5.7.1 Ureaplasma & Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • 5.8 Trichomonas Testing
    • 5.8.1 Trichomonas Testing Market, 2018 - 2030 (USD Million)
  • 5.9 Vzv Testing
    • 5.9.1 Vzv Testing Market, 2018 - 2030 (USD Million)
    • 5.9.2 Vzv Pcr Testing Market, 2018 - 2030 (USD Million)
    • 5.9.3 Vzv Non-Pcr Testing Market, 2018 - 2030 (USD Million)
  • 5.10 Gonorrheatesting
    • 5.10.1 Gonorrhea Testing Market, 2018 - 2030 (USD Million)
  • 5.11 Other Testing
    • 5.11.1 Other Testing Market, 2018 - 2030 (USD Million)

Chapter 6 STD Diagnostics Market: Segment Analysis, By Technology, 2018-2030 (USD Million)

  • 6.1 STD Diagnostics Market: Technology Movement Analysis
  • 6.2 Molecular Diagnostics
    • 6.2.1 Molecular Diagnostics Market, 2018 - 2030 (USD Million)
  • 6.3 Immunoassay
    • 6.3.1 Immunoassay Market, 2018 - 2030 (USD Million)
  • 6.4 Others
    • 6.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 STD Diagnostics Market: Segment Analysis, By Location Of Testing, 2018 - 2030 (USD Million)

  • 7.1 STD Diagnostics Market: Location Of Testing Movement Analysis
  • 7.2 Laboratory Testing
    • 7.2.1 Laboratory Testing Market, 2018 - 2030 (USD Million)
    • 7.2.2 Commercial/Private Labs
      • 7.2.2.1 Commercial/Private Labs Market, 2018 - 2030 (USD Million)
    • 7.2.3 Public Health Labs
      • 7.2.3.1 Public Health Labs Market, 2018 - 2030 (USD Million)
  • 7.3 Point Of Care Testing
    • 7.3.1 Point Of Care Testing Market, 2018 - 2030 (USD Million)

Chapter 8 STD Diagnostics Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 8.1 STD Diagnostics Market: Regional Outlook
  • 8.2 North America
    • 8.2.1 North America STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 U.S. STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.2.2.3 Target Disease: Cancer Incidence
      • 8.2.2.4 Market And Competitive Scenario
      • 8.2.2.5 Regulatory Framework
      • 8.2.2.6 Reimbursement Scenario
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Canada STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.2.3.3 Target Disease: Cancer Incidence
      • 8.2.3.4 Market And Competitive Scenario
      • 8.2.3.5 Regulatory Framework
      • 8.2.3.6 Reimbursement Scenario
  • 8.3 Europe
    • 8.3.1 Europe STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2 UK
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 Uk STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.3 Target Disease Prevalence
      • 8.3.2.4 Market And Competitive Scenario
      • 8.3.2.5 Regulatory Framework
      • 8.3.2.6 Reimbursement Scenario
    • 8.3.3 Germany
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Germany STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.3.3 Target Disease Prevalence
      • 8.3.3.4 Market And Competitive Scenario
      • 8.3.3.5 Regulatory Framework
      • 8.3.3.6 Reimbursement Scenario
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 France STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.4.3 Target Disease Prevalence
      • 8.3.4.4 Market And Competitive Scenario
      • 8.3.4.5 Regulatory Framework
      • 8.3.4.6 Reimbursement Scenario
    • 8.3.5 Spain
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Spain STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.5.3 Target Disease Prevalence
      • 8.3.5.4 Market And Competitive Scenario
      • 8.3.5.5 Regulatory Framework
      • 8.3.5.6 Reimbursement Scenario
    • 8.3.6 Italy
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Italy STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.6.3 Target Disease Prevalence
      • 8.3.6.4 Market And Competitive Scenario
      • 8.3.6.5 Regulatory Framework
      • 8.3.6.6 Reimbursement Scenario
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Denmark STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.7.3 Target Disease Prevalence
      • 8.3.7.4 Market And Competitive Scenario
      • 8.3.7.5 Regulatory Framework
      • 8.3.7.6 Reimbursement Scenario
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Sweden STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.8.3 Target Disease Prevalence
      • 8.3.8.4 Market And Competitive Scenario
      • 8.3.8.5 Regulatory Framework
      • 8.3.8.6 Reimbursement Scenario
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Norway STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.9.3 Target Disease Prevalence
      • 8.3.9.4 Market And Competitive Scenario
      • 8.3.9.5 Regulatory Framework
      • 8.3.9.6 Reimbursement Scenario
    • 8.3.10 Rest Of Europe STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Japan STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.2.3 Target Disease Prevalence
      • 8.4.2.4 Market And Competitive Scenario
      • 8.4.2.5 Regulatory Framework
      • 8.4.2.6 Reimbursement Scenario
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 China STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.3.3 Target Disease Prevalence
      • 8.4.3.4 Market And Competitive Scenario
      • 8.4.3.5 Regulatory Framework
      • 8.4.3.6 Reimbursement Scenario
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 India STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.4.3 Target Disease Prevalence
      • 8.4.4.4 Market And Competitive Scenario
      • 8.4.4.5 Regulatory Framework
      • 8.4.4.6 Reimbursement Scenario
    • 8.4.5 Australia
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Australia STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.5.3 Target Disease Prevalence
      • 8.4.5.4 Market And Competitive Scenario
      • 8.4.5.5 Regulatory Framework
      • 8.4.5.6 Reimbursement Scenario
    • 8.4.6 Thailand
      • 8.4.6.1 Key Country Dynamics
      • 8.4.6.2 Thailand STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.6.3 Target Disease Prevalence
      • 8.4.6.4 Market And Competitive Scenario
      • 8.4.6.5 Regulatory Framework
      • 8.4.6.6 Reimbursement Scenario
    • 8.4.7 South Korea
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 South Korea STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.7.3 Target Disease Prevalence
      • 8.4.7.4 Market And Competitive Scenario
      • 8.4.7.5 Regulatory Framework
      • 8.4.7.6 Reimbursement Scenario
    • 8.4.8 Rest Of Asia Pacific STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Brazil STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.5.2.3 Target Disease Prevalence
      • 8.5.2.4 Competitive Scenario
      • 8.5.2.5 Regulatory Framework
      • 8.5.2.6 Reimbursement Scenario
    • 8.5.3 Mexico
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Mexico STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.5.3.3 Target Disease Prevalence
      • 8.5.3.4 Competitive Scenario
      • 8.5.3.5 Regulatory Framework
      • 8.5.3.6 Reimbursement Scenario
    • 8.5.4 Argentina
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Argentina STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.5.4.3 Target Disease Prevalence
      • 8.5.4.4 Competitive Scenario
      • 8.5.4.5 Regulatory Framework
      • 8.5.4.6 Reimbursement Scenario
    • 8.5.5 Rest Of Latin America STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6 Mea
    • 8.6.1 Mea STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 Key Country Dynamics
      • 8.6.2.2 South Africa STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.2.3 Target Disease Prevalence
      • 8.6.2.4 Competitive Scenario
      • 8.6.2.5 Regulatory Framework
      • 8.6.2.6 Reimbursement Scenario
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Saudi Arabia STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.3.3 Target Disease Prevalence
      • 8.6.3.4 Competitive Scenario
      • 8.6.3.5 Regulatory Framework
      • 8.6.3.6 Reimbursement Scenario
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 Uae STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.4.3 Target Disease Prevalence
      • 8.6.4.4 Competitive Scenario
      • 8.6.4.5 Regulatory Framework
      • 8.6.4.6 Reimbursement Scenario
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Kuwait STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.5.3 Target Disease Prevalence
      • 8.6.5.4 Competitive Scenario
      • 8.6.5.5 Regulatory Framework
      • 8.6.5.6 Reimbursement Scenario
    • 8.6.6 Rest Of Mea STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9 STD Diagnostics Market: Competitive Analysis

  • 9.1 Recent Developments And Impact Analysis, By Key Market Participants
    • 9.1.1 New Product Launches
    • 9.1.2 Mergers And Acquisitions
    • 9.1.3 Partnerships And Strategic Collaboration
    • 9.1.4 Conferences And Campaigns
  • 9.2 Company Categorization
    • 9.2.1 Innovators
    • 9.2.2 Market Leaders
    • 9.2.3 Heat Map Analysis
  • 9.3 Vendor Landscape
    • 9.3.1 List Of Key Distributors And Channel Partners
    • 9.3.2 Key Customers
  • 9.4 Key Company Market Share Analysis, 2022
  • 9.5 Public Companies
    • 9.5.1 Company Market Position Analysis
    • 9.5.2 Competitive Dashboard Analysis
      • 9.5.2.1 Market Differentiators
  • 9.6 Private Companies
    • 9.6.1 List Of Key Emerging Companies
    • 9.6.2 Regional Network Map
  • 9.7 Company Profiles
    • 9.7.1 BD
      • 9.7.1.1 Company Overview
      • 9.7.1.2 Financial Performance
      • 9.7.1.3 Product benchmarking
      • 9.7.1.4 Strategic initiatives
    • 9.7.2 F. HOFFMANN-LA ROCHE LTD.
      • 9.7.2.1 Company overview
      • 9.7.2.2 Financial Performance
      • 9.7.2.3 Product benchmarking
      • 9.7.2.4 Strategic initiatives
    • 9.7.3 HOLOGIC INC. (GEN PROBE)
      • 9.7.3.1 Company Overview
      • 9.7.3.2 Financial Performance
      • 9.7.3.3 Product Benchmarking
      • 9.7.3.4 Strategic Initiatives
    • 9.7.4 ABBOTT
      • 9.7.4.1 Company Overview
      • 9.7.4.2 Financial Performance
      • 9.7.4.3 Product Benchmarking
      • 9.7.4.4 Strategic Initiatives
    • 9.7.5 CEPHEID (DANAHER)
      • 9.7.5.1 Company Overview
      • 9.7.5.2 Financial Performance
      • 9.7.5.3 Product Benchmarking
      • 9.7.5.4 Strategic Initiatives
    • 9.7.6 QIAGEN
      • 9.7.6.1 Company Overview
      • 9.7.6.2 Financial Performance
      • 9.7.6.3 Product Benchmarking
      • 9.7.6.4 Strategic Initiatives
    • 9.7.7 ORASURE TECHNOLOGIES, INC
      • 9.7.7.1 Company Overview
      • 9.7.7.2 Financial Performance
      • 9.7.7.3 Product Benchmarking
      • 9.7.7.4 Strategic Initiatives
    • 9.7.8 BIO-RAD LABORATORIES, INC.
      • 9.7.8.1 Company Overview
      • 9.7.8.2 Financial Performance
      • 9.7.8.3 Product Benchmarking
      • 9.7.8.4 Strategic Initiatives
    • 9.7.9 BIOMERIEUX SA
      • 9.7.9.1 Company overview
      • 9.7.9.2 Financial Performance
      • 9.7.9.3 Product benchmarking
      • 9.7.9.4 Strategic initiatives
    • 9.7.10 THERMO FISHER SCIENTIFIC, INC.
      • 9.7.10.1 Company overview
      • 9.7.10.2 Financial performance
      • 9.7.10.3 Product benchmarking
      • 9.7.10.4 Strategic initiatives
    • 9.7.11 SEEGENE INC.
      • 9.7.11.1 Company overview
      • 9.7.11.2 Financial performance
      • 9.7.11.3 Product benchmarking
      • 9.7.11.4 Strategic initiatives
    • 9.7.12 DIASORIN S.P.A
      • 9.7.12.1 Company overview
      • 9.7.12.2 Financial performance
      • 9.7.12.3 Product benchmarking
      • 9.7.12.4 Strategic initiatives

Chapter 10 Conclusion

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 List of key distributors
  • Table 4 List of other companies
  • Table 5 List of key emerging companies/technology disruptors/innovators
  • Table 6 Global STD Diagnostics Market, By Region, 2018 - 2030 (USD Million)
  • Table 7 Global STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 Global STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 9 Global STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 10 Global STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 11 North America STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 12 North America STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 North America STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 14 North America STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 15 North America STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 16 U.S. STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 17 U.S. STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 18 U.S. STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 19 U.S. STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 20 Canada STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Canada STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 22 Canada STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 Canada STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 24 Europe STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 25 Europe STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 Europe STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 27 Europe STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 28 Europe STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 29 UK STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 30 UK STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 31 UK STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 UK STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 33 Germany STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 34 Germany STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 35 Germany STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Germany STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 37 France STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 38 France STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 39 France STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 40 France STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 41 Spain STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 42 Spain STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 43 Spain STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Spain STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 45 Italy STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Italy STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 47 Italy STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Italy STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 49 Denmark STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 50 Denmark STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 51 Denmark STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Denmark STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 53 Sweden STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 Sweden STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 55 Sweden STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 56 Sweden STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 57 Norway STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 58 Norway STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 59 Norway STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 Norway STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 66 Japan STD Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 67 Japan STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 68 Japan STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 Japan STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 70 China STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 71 China STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 72 China STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 73 China STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 74 India STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 75 India STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 76 India STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 India STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 78 Australia STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 79 Australia STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 80 Australia STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 81 Australia STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 82 South Korea STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 83 South Korea STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 84 South Korea STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 85 South Korea STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 86 Thailand STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 87 Thailand STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 88 Thailand STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 Thailand STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 90 Latin America STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 91 Latin America STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 92 Latin America STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 93 Latin America STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 94 Latin America STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 95 Brazil STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 96 Brazil STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 97 Brazil STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 98 Brazil STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 99 Mexico STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 100 Mexico STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 101 Mexico STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 102 Mexico STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 103 Argentina STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 104 Argentina STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 105 Argentina STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 106 Argentina STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 107 MEA STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 108 MEA STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 109 MEA STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 110 MEA STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 111 MEA STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 112 South Africa STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 113 South Africa STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 114 South Africa STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 115 South Africa STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 117 Saudi Arabia STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 118 Saudi Arabia STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 119 Saudi Arabia STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 120 UAE STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 121 UAE STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 122 UAE STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 123 UAE STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 124 Kuwait STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 125 Kuwait STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 126 Kuwait STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 127 Kuwait STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 STD Diagnostics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Penetration and growth prospect mapping
  • Fig. 11 User perspective analysis
  • Fig. 12 STD Diagnostics Market driver impact
  • Fig. 13 Prevalence of STIs by WHO regions (in 2023)
  • Fig. 14 STD Diagnostics Market restraint impact
  • Fig. 15 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 16 Porter's Five Forces Analysis
  • Fig. 17 STD diagnostics product outlook: Key takeaways
  • Fig. 18 STD Diagnostics Market: Product movement analysis
  • Fig. 19 Instruments and Services market, 2018 - 2030 (USD Million)
  • Fig. 20 Consumables market, 2018 - 2030 (USD Million)
  • Fig. 21 Software market, 2018 - 2030 (USD Million)
  • Fig. 22 STD diagnostics application outlook: Key takeaways
  • Fig. 23 STD Diagnostics Market: Application movement analysis
  • Fig. 24 CT/NG testing market, 2018 - 2030 (USD Million)
  • Fig. 25 Prevalence (%) of syphilis by WHO regions
  • Fig. 26 Syphilis testing market, 2018 - 2030 (USD Million)
  • Fig. 27 Syphilis PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 28 Syphilis non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 29 HSV testing market, 2018 - 2030 (USD Million)
  • Fig. 30 Herpes Simplex Virus PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 31 Herpes Simplex Virus non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 32 HPV testing market, 2018 - 2030 (USD Million)
  • Fig. 33 Prevalence (%) of HIV by WHO regions
  • Fig. 34 HIV testing market, 2018 - 2030 (USD Million)
  • Fig. 35 Ureaplasma & mycoplasma testing market, 2018 - 2030 (USD Million)
  • Fig. 36 Trichomonas testing market, 2018 - 2030 (USD Million)
  • Fig. 37 VZV testing market, 2018 - 2030 (USD Million)
  • Fig. 38 VZV PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 39 VZV non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 40 Other testing market, 2018 - 2030 (USD Million)
  • Fig. 41 STD diagnostics technology outlook: Key takeaways
  • Fig. 42 STD Diagnostics Market: Technology movement analysis
  • Fig. 43 Molecular Diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 44 Immunoassay market, 2018 - 2030 (USD Million)
  • Fig. 45 Others market, 2018 - 2030 (USD Million)
  • Fig. 46 STD diagnostics location of testing outlook: Key takeaways
  • Fig. 47 STD Diagnostics Market: Location of testing movement analysis
  • Fig. 48 Laboratory testing market, 2018 - 2030 (USD Million)
  • Fig. 49 Commercial/private labs market, 2018 - 2030 (USD Million)
  • Fig. 50 Public health labs market, 2018 - 2030 (USD Million)
  • Fig. 51 Point of care testing market, 2018 - 2030 (USD Million)
  • Fig. 52 Regional outlook, 2023 & 2030
  • Fig. 53 Regional marketplace: Key takeaways
  • Fig. 54 North America SWOT
  • Fig. 55 North America STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 56 U.S. Country Dynamics
  • Fig. 57 U.S. Target Disease Prevalence
  • Fig. 58 U.S. STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Canada Country Dynamics
  • Fig. 60 Canada Target Disease Prevalence
  • Fig. 61 Canada STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 62 Europe SWOT
  • Fig. 63 Europe STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 64 UK Country Dynamics
  • Fig. 65 UK Target Disease Prevalence
  • Fig. 66 UK STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 67 Germany Country Dynamics
  • Fig. 68 GermanyTarget Disease Prevalence
  • Fig. 69 Germany STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 70 France Country Dynamics
  • Fig. 71 France Target Disease Prevalence
  • Fig. 72 France STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 73 Spain Country Dynamics
  • Fig. 74 Spain Target Disease Prevalence
  • Fig. 75 Spain STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 76 Italy Country Dynamics
  • Fig. 77 Italy Target Disease Prevalence
  • Fig. 78 Italy STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 79 Denmark Country Dynamics
  • Fig. 80 Denmark Target Disease Prevalence
  • Fig. 81 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 82 Sweden Country Dynamics
  • Fig. 83 Sweden Target Disease Prevalence
  • Fig. 84 Sweden STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 85 Denmark Country Dynamics
  • Fig. 86 Denmark Target Disease Prevalence
  • Fig. 87 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 88 Asia Pacific SWOT
  • Fig. 89 Asia Pacific STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 90 Japan Country Dynamics
  • Fig. 91 Japan Target Disease Prevalence
  • Fig. 92 Japan STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 93 China Country Dynamics
  • Fig. 94 China Target Disease Prevalence
  • Fig. 95 China STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 96 India Country Dynamics
  • Fig. 97 India Target Disease Prevalence
  • Fig. 98 India STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 99 Australia Country Dynamics
  • Fig. 100 Australia Target Disease Prevalence
  • Fig. 101 Australia STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 102 South Korea Country Dynamics
  • Fig. 103 South Korea Target Disease Prevalence
  • Fig. 104 South Korea STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 105 Thailand Country Dynamics
  • Fig. 106 Thailand Target Disease Prevalence
  • Fig. 107 Thailand STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 108 Latin America SWOT
  • Fig. 109 Latin America STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 110 Brazil Country Dynamics
  • Fig. 111 Brazil Target Disease Prevalence
  • Fig. 112 Brazil STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 113 Mexico Country Dynamics
  • Fig. 114 Mexico Target Disease Prevalence
  • Fig. 115 Mexico STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 116 Argentina Country Dynamics
  • Fig. 117 Argentina Target Disease Prevalence
  • Fig. 118 Argentina STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 119 Middle East & Africa SWOT
  • Fig. 120 Middle East & Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 121 South Africa Country Dynamics
  • Fig. 122 South Africa Target Disease Prevalence
  • Fig. 123 South Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 124 Saudi Arabia Country Dynamics
  • Fig. 125 Saudi Arabia Target Disease Prevalence
  • Fig. 126 Saudi Arabia STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 127 UAE Country Dynamics
  • Fig. 128 UAE Target Disease Prevalence
  • Fig. 129 UAE STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 130 Kuwait Country Dynamics
  • Fig. 131 Kuwait Target Disease Prevalence
  • Fig. 132 Kuwait STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 133 Heat map analysis
  • Fig. 134 Company market share analysis (2023)
  • Fig. 135 Company market position analysis (2023)
  • Fig. 136 Company market position analysis (2023)
  • Fig. 137 Market differentiators
  • Fig. 138 Regional Network Map